Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 06-2014 | 06-2013 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,487 | N/A | 8,149 | 6,700 | 1,982 |
| Depreciation Amortization | 335 | N/A | 1,649 | 1,670 | 1,628 |
| Income taxes - deferred | N/A | N/A | -258 | -270 | 15 |
| Accounts receivable | N/A | N/A | 4,740 | -3,439 | -945 |
| Accounts payable and accrued liabilities | N/A | N/A | -650 | 875 | 989 |
| Other Working Capital | 2,121 | N/A | 113 | -1,919 | -975 |
| Other Operating Activity | 1,688 | 0 | -4,390 | 1,615 | 5,231 |
| Operating Cash Flow | $-26,343 | $N/A | $9,353 | $5,232 | $7,925 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -508 | N/A | -1,485 | -792 | -1,060 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -1,560 |
| Other Investing Activity | 0 | 0 | 529 | 0 | 0 |
| Investing Cash Flow | $-508 | $N/A | $-956 | $-792 | $-2,620 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -40 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 72 | N/A | 142 | 286 | 79 |
| Common Stock Repurchased | N/A | N/A | 0 | 0 | -966 |
| Dividend Paid | N/A | N/A | -7,283 | -6,550 | -9,005 |
| Other Financing Activity | 48,595 | 0 | 173 | 27 | -2,483 |
| Financing Cash Flow | $48,627 | $N/A | $-6,968 | $-6,237 | $-12,375 |
| Beginning Cash Position | 13,634 | N/A | 22,816 | 24,613 | 31,683 |
| End Cash Position | 35,410 | N/A | 24,245 | 22,816 | 24,613 |
| Net Cash Flow | $21,776 | $N/A | $1,429 | $-1,797 | $-7,070 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,343 | N/A | 9,353 | 5,232 | 7,925 |
| Capital Expenditure | -508 | N/A | -1,485 | -792 | -1,060 |
| Free Cash Flow | -26,851 | 0 | 7,868 | 4,440 | 6,865 |